Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma-Reference-Cited by-同舟云学术

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

Published:2021-02 Issue:2 Volume:159 Page:496-506
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Kavanagh Joanne E.,Hearn Andrew P.,Dhariwal Jaideep,d’Ancona Gráinne,Douiri Abdel,Roxas Cris,Fernandes Mariana,Green Linda,Thomson Louise,Nanzer Alexandra M.,Kent Brian D.,Jackson David J.

Funder

AstraZeneca

Chiesi

Teva

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference21 articles.

1. The prevalence of severe refractory asthma;Hekking;J Allergy Clin Immunol,2015

2. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001

3. Real-world effectiveness and the characteristics of a “super-responder” to mepolizumab in severe eosinophilic asthma;Kavanagh;Chest,2020

4. Safety of eosinophil-depleting therapy for severe, eosinophilic asthma: focus on benralizumab;Jackson;Drug Saf,2020

5. Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions;Walsh;Curr Opin Mol Ther,2009

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab responder types and predicting factors in patients with type 2 severe asthma: A real-world cohort study;Respiratory Medicine;2024-09

2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

3. Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM study;World Allergy Organization Journal;2024-09

4. Navigating the Terrain: Type 2 Cytokines and Biologic intervention in Severe Eosinophilic Asthma;Eosinophils and Their Role in Human Health and Disease [Working Title];2024-08-23

5. Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database;Journal of Clinical Medicine;2024-07-18